The m6A-related gene signature for predicting the prognosis of breast cancer

The m6A-related gene signature for predicting the prognosis of breast cancer

N6-methyladenosine (m6A) modification has been shown to participate in tumorigenesis and metastasis of human cancers. The present study aimed to investigate the roles of m6A RNA methylation regulators in breast cancer. We used LASSO regression to identify m6A-related gene signature predicting breast...

Full description

Bibliographic Details
Main Authors:	Shanliang Zhong, Zhenzhong Lin, Huanwen Chen, Ling Mao, Jifeng Feng, Siying Zhou
Format:	Article
Language:	English
Published:	PeerJ Inc. 2021-06-01
Series:	PeerJ
Subjects:	Breast cancer Breast neoplasms m6A modification IGF2BP1 Prognosis
Online Access:	https://peerj.com/articles/11561.pdf

Similar Items

Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy
by: Shanliang Zhong, et al.
Published: (2020-07-01)

Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
by: Gang Bao, et al.
Published: (2020-01-01)

Prognosis of breast cancer : a survival analysis of 1184 patients with 4-10 years follow-up, illustrating the relative importance of estrogen receptors, axillary nodes, clinical stage and tumor necrosis
by: Shek, Lydia L. M.
Published: (2010)

Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer
by: Bo Zhang, et al.
Published: (2020-12-01)

Breast cancer biomarkers: Prognosis and prediction
by: Nešković-Konstantinović Zora B., et al.
Published: (2002-01-01)

Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer
by: Fangchao Zheng, et al.
Published: (2021-04-01)

Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer
by: Jinguo Zhang, et al.
Published: (2021-10-01)

Similar Prognosis of Patients with Bone-only Metastatic Breast Cancer and Visceral Metastasis
by: Ryutaro Mori, et al.
Published: (2021-01-01)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
by: Xinwei Huang, et al.
Published: (2018-06-01)

The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers
by: Jinyan Wang, et al.
Published: (2021-02-01)

Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer
by: Xiao-Han Cui, et al.
Published: (2020-11-01)

The Complex Roles and Therapeutic Implications of m6A Modifications in Breast Cancer
by: Min Wei, et al.
Published: (2021-01-01)

Understanding the roles of N6-methyladenosine writers, readers and erasers in breast cancer
by: Runping Fang, et al.
Published: (2021-06-01)

Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer
by: Haoyu Wang, et al.
Published: (2020-02-01)

Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
by: Xinyi Wang, et al.
Published: (2020-05-01)

m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
by: Chuandong Lang, et al.
Published: (2021-06-01)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
by: Lu W, et al.
Published: (2020-11-01)

Prognosis for patients diagnosed with pregnancy-associated breast cancer: a paired case-control study
by: Wagner Brant Moreira, et al.

The mode of progressive disease affects the prognosis of patients with metastatic breast cancer
by: Ryutaro Mori, et al.
Published: (2018-08-01)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
by: Jinfang Liu, et al.
Published: (2021-08-01)

The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
by: Zibo Meng, et al.
Published: (2020-06-01)

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
by: Ting Li, et al.
Published: (2019-06-01)

Influence of Androgen Receptor on the Prognosis of Breast Cancer
by: Ki-Tae Hwang, et al.
Published: (2020-04-01)

Molecular Characteristics, Prognostic Value, and Immune Characteristics of m6A Regulators Identified in Head and Neck Squamous Cell Carcinoma
by: Xiuchao Geng, et al.
Published: (2021-03-01)

The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
by: Xia Wang, et al.
Published: (2021-07-01)

Influence of some breast cancer prognostic factors in older women
by: Veselinović Slavica, et al.
Published: (2002-01-01)

Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study
by: Hosein Kamranzadeh, et al.
Published: (2019-01-01)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
by: Bin Xiao, et al.
Published: (2018-04-01)

LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
by: Pingfu Hou, et al.
Published: (2021-02-01)

Prognostic significance of steroid hormone receptors (ER and PR) in primary operable breast cancer
by: Kanjer Ksenija, et al.
Published: (2002-01-01)

The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database
by: Yongfeng Li, et al.
Published: (2019-09-01)

Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer
by: Menglin He, et al.
Published: (2021-10-01)

Relationship of ITPKA expression with the prognosis of breast cancer
by: Jie Zhang, et al.
Published: (2021-04-01)

Correlations between IGF-IR Expression and Clinicopathological Factors and Prognosis in Patients with Lung Adenocarcinoma
by: Xueyan ZHANG, et al.
Published: (2010-12-01)

IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
by: Ning Dai, et al.
Published: (2017-07-01)

Effect of isoflavone consumptions on the recurrence and survival rate among breast cancer patients: an evidence-based case report
by: Meilianawati Meilianawati, et al.
Published: (2020-08-01)

Metastatic breast cancer: clinicopathological features and survival according to the site of metastasis
by: Igor Vilela Brum, et al.
Published: (2017-06-01)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
by: Hung-Ming Chen, et al.
Published: (2021-06-01)

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
by: Flavia R. Mangone, et al.
Published: (2012-11-01)

Prognostic and Predictive Factors of Early Breast Cancer
by: Zhong-jie CHEN, et al.
Published: (2010-08-01)

Cannot write session to /tmp/vufind_sessions/sess_vhsfg06o9ofm43rred70pqb0kg